A Combined Screening Platform for HIV Treatment Failure and Resistance

@inproceedings{Tilghman2012ACS,
  title={A Combined Screening Platform for HIV Treatment Failure and Resistance},
  author={Myres W. Tilghman and Susanne J. May and Josu{\'e} P{\'e}rez-Santiago and Caroline C. Ignacio and Susan J. Little and Douglas D. Richman and Davey M. Smith},
  booktitle={PloS one},
  year={2012}
}
BACKGROUND To develop a low cost method to screen for virologic failure of antiretroviral therapy (ART) and HIV-1 drug resistance, we performed a retrospective evaluation of a screening assay using serial dilutions of HIV-1 RNA-spiked blood plasma and samples from patients receiving >6 months of first-line ART. METHODS Serial dilution testing was used to assess sensitivity of a simple PCR-based assay (targeted at ≥1,000 HIV RNA copies/mL). We created blood plasma minipools of five samples… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 12 references

Pooled nucleic acid testing to detect antiretroviral treatment failure in Mexico.

Journal of acquired immune deficiency syndromes • 2011
View 3 Excerpts

Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2011
View 3 Excerpts

Rationale and uses of a public HIV drug-resistance database.

The Journal of infectious diseases • 2006
View 1 Excerpt

Similar Papers

Loading similar papers…